Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;37(3):daac078.
doi: 10.1093/heapro/daac078.

COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature

Affiliations

COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature

Umair Majid et al. Health Promot Int. .

Abstract

As countries continue the third year of the pandemic, we believe that there has been unfair attention to COVID-19 vaccine efficacy and safety, while tacitly ignoring serious challenges with vaccine uptake, without which vaccination may not be effective against the spread of COVID-19. While several studies have been published on COVID-19 vaccine hesitancy, there remains a need to conduct a comprehensive global analysis of vaccine hesitancy. We conducted a scoping review of 60 studies published globally on vaccine hesitancy and acceptance. We conducted a qualitative analysis to identify motivators and barriers to vaccination across several cultural and demographic contexts. We found the following factors to be relevant in any discussion about addressing or minimizing vaccine hesitancy: risk perceptions, trust in health care systems, solidarity, previous experiences with vaccines, misinformation, concerns about vaccine side effects and political ideology. We combine our insights from this comprehensive review of global literature to offer an important and practical discussion about two strategies that have been used to improve vaccine uptake: (i) communication and education and (ii) vaccine rollout and logistics.

Keywords: COVID-19; SARS-CoV-2; pandemic planning; scoping review; vaccine hesitancy.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:
Screening and selection process.

Similar articles

Cited by

References

    1. Abdelhafiz, A. S., Mohammed, Z., Ibrahim, M. E., Ziady, H. H., Alorabi, M., Ayyad, M.et al. (2020) Knowledge, perceptions, and attitude of Egyptians towards the novel coronavirus disease (COVID-19). Journal of Community Health, 45, 881–890. - PMC - PubMed
    1. Abrams, E. M. and Greenhawt, M. (2020) Risk communication during COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 8, 1791–1794. - PMC - PubMed
    1. Abu-Farha, R. K., Alzoubi, K. H. and Khabour, O. F. (2020) Public willingness to participate in COVID-19 vaccine clinical trials: a study from Jordan. Patient Preference and Adherence, 14, 2451–2458. - PMC - PubMed
    1. Ahmad, M., Truong, J. and Majid, U. (2020) Let’s talk COVID-19 vaccine hesitancy. Longwoods. https://www.longwoods.com/content/26286//let-s-talk-covid-19-vaccine-hes... (last accessed 20 February 2021).
    1. Akarsu, B., Canbay Özdemir, D., Ayhan Baser, D., Aksoy, H., Fidancı, I. and Cankurtaran, M. (2021) While studies on COVID-19 vaccine are ongoing, the public’s thoughts and attitudes to the future COVID-19 vaccine. International Journal of Clinical Practice, 75, e13891. - PMC - PubMed

Publication types

Substances